On Jul. 9, 2020, BioReference Laboratories, an OPKO Health company, announced that it will conduct COVID-19 testing for all Major League Soccer (MLS) players as well as match officials, and Club and League staff participating in the MLS is Back Tournament. MLS chose BioReference as its laboratory to assist in informing its return-to-play policies for the Tournament kicking off in Orlando in early July.

In addition to providing testing to players, match officials, and staff, MLS is working with BioReference to provide COVID-19 antibody testing to the Orlando community. MLS is supporting the latest community collection location at the Orlando Vineland Premium Outlets, which began on July 6.

BioReference provides comprehensive testing to physicians, clinics, hospitals, employers, government units, correctional institutions and medical groups. BioReference has been working expeditiously to develop and offer test services that will yield high quality and accurate results, including a molecular test for helping with COVID-19 diagnosis and a serology test to help indicate possible COVID-19 exposure.

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies.